Nos publications
QbD - How particle size and glyceride composition affect the performance of sustained-release tablets with Compritol 888 ATO
AAPS Annual Meeting & Exposition – San Diego (USA) - nov 2017
A Systematic Approach to Lipid-Based Formulation Development for a Poorly Soluble API, Fenofibrate
AAPS Annual Meeting & Exposition – San Diego (USA) - nov 2017
Taste-masked drugs for pediatric medicines through lipid coating
AAPS Annual Meeting & Exposition – San Diego (USA) - nov 2017
Macrogol esters: Influence on in vitro and in vivo dissolution of a poorly soluble drug
AAPS Annual Meeting & Exposition – San Diego (USA) - nov 2017
Gelucire 48/16®: A Non-Ionic Solid Surfactant for Solubility Enhancement of Poorly Soluble Drugs
AAPS Annual Meeting & Exposition – San Diego (USA) - nov 2017
Compritol® 888 ATO: a sustained release lipid matrix for once a day aceclofenac tablets
AAPS Annual Meeting & Exposition – Denver (USA) - nov 2017
LIPID-BASED DELIVERY – Are Lipid-Based Drug Delivery Systems in Your Formulation Toolbox?
Drug Development & Delivery, Vol. 17, No. 7, p.20-25 - oct 2017
This article reviews the causes of poor bioavailability for drugs. It provides an introduction to lipid-based drug delivery systems, and how the formulation approach can be used to overcome impediments to good bioavailability of therapeutic actives, including poor water solubility, low permeability, and degradation by stomach acid or enzymes in vivo.
Efficient taste masking through high shear coating
9th Conference of the European Paediatric Formulation Initiative - 2017
Attractive emollient foams for pain treatments
Skinforum Annual Meeting - jui 2017